Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: In a previous single dosing comparison between fluticasone propionate and budesonide differences in cortisol levels measured at 08.00 hours were observed at doses in excess of 1000 micrograms. The aim of this study was to compare the adrenal suppression caused by chronic twice daily dosing with inhaled fluticasone propionate (FP) and budesonide (B) given on a microgram equivalent basis by metered dose inhaler to asthmatic patients. METHODS: Twelve stable asthmatic patients of mean age 29.7 years with forced expiratory volume in one second (FEV1) 89.0% predicted and mid forced expiratory flow (FEF25-75) 58.9% predicted, on 400 micrograms/day or less of inhaled corticosteroid, were studied in a double blind, placebo controlled, crossover design comparing inhaled budesonide and fluticasone propionate in doses of 250 micrograms, 500 micrograms, and 1000 micrograms twice daily. Each dose was given at 08.00 hours and 22.00 hours for four days by metered dose inhaler with mouth rinsing. Measurements were made of overnight urinary cortisol excretion and plasma cortisol levels at 08.00 hours, 10 hours after the eighth dose. RESULTS: The plasma cortisol levels (nmol/ l) at 08.00 hours showed that fluticasone propionate produced lower cortisol levels than budesonide at all three dose levels: F500 333.8, B500 415.2 (95% CI 28.9 to 134.0); F1000 308.3, B1000 380.3 (95% CI 10.5 to 133.5); F2000 207.3, B2000 318.5 (95% CI 5.8 to 216.7); placebo 399.9. Fluticasone produced greater effects than budesonide on the overnight urinary cortisol/creatinine ratio (nmol/mmol) at all three dose levels: F500 3.12, B500 5.55 (95% CI 0.16 to 3.79); F1000 2.54, B1000 6.12 (95% CI 1.25 to 5.91); F2000 2.07, B2000 6.09 (95% CI 0.88 to 7.18); placebo 5.23. CONCLUSIONS: With repeated dosing across a dose range of 250-1000 micrograms twice daily, fluticasone propionate produced significantly greater adrenal suppression than budesonide for both plasma and urinary cortisol. It was therefore possible to demonstrate differences between fluticasone and budesonide at lower doses with chronic dosing from those previously found with single dosing when given on a microgram equivalent basis in asthmatic patients. Factors contributing to the systemic adverse activity profile of fluticasone comprise enhanced receptor potency, prolonged receptor residency time, greater tissue retention, and a longer elimination half life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
“0 mg/d via metered-dose inhaler alone.(31) In the same study, for doses of up to 1 mg/d, 14 of 24 vs 1 of 24 had low cortisol values when given fluticasone propionate and budesonide, respectively.”
BackgroundMethodInfluentialSelf-citationGlucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Savas, M., Muka, T., Wester, V. L., van den Akker, E. L. T., Visser, J. A., Braunstahl, G.-J., Slagter, S. N., Wolffenbuttel, B. H. R., Franco, O. H., & van Rossum, E. F. C. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01133 · Cited by 58
Hypothalamic-Pituitary-Adrenal Axis Suppression and Inhaled Corticosteroid Therapy
Chrousos, G. P., & Harris, A. G. (1998) · Neuroimmunomodulation · doi:10.1159/000026348 · Cited by 50
The effect of a steroid “burst” and long-term, inhaled fluticasone propionate on adrenal reserve
Nguyen, K.-L., Lauver, D., Kim, I., & Aresery, M. (2003) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62056-x · Cited by 20
Metadata
- Authors
- Clark, D. J., & Lipworth, B. J.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 1997-01-01
- Volume
- 52
- Issue
- 1
- Pages
- 55-58
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2019485286
- Cited by
- 125
- References
- 0
- FWCI
- 13.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. https://app.cochat.ai/papers/10.1136/thx.52.1.55
- The paper
- Clark, D. J., & Lipworth, B. J. (1997). Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax. https://doi.org/10.1136/thx.52.1.55
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.